New brain cancer treatment trial seeks to extend survival
Disease control
Ongoing
This study is testing whether adding an experimental drug called BPM31510 to standard radiation and chemotherapy can help people with newly diagnosed glioblastoma, an aggressive brain cancer. The main goal is to see if this combination can delay cancer progression and extend surv…
Phase: PHASE2 • Sponsor: BPGbio • Aim: Disease control
Last updated Apr 01, 2026 14:42 UTC